Spectrum of Severity of Multisystem Inflammatory Syndrome in Children: An EHR-based Cohort Study from the RECOVER program

dc.contributorNational Institutes of Health
dc.contributor.authorSuchitra Rao
dc.contributor.authorChen, Yong
dc.contributor.otherHospital of the University of Pennsylvania
dc.date.accessioned2024-11-18T21:07:17Z
dc.descriptionMulti-system inflammatory syndrome in children (MIS-C) is a severe post-acute sequela of SARS-CoV-2 infection in children, and there is a critical need to unfold its highly heterogeneous disease patterns. Our objective was to characterize the illness spectrum of MIS-C for improved recognition and management. We conducted a retrospective cohort study using data from March 1, 2020–September 30, 2022, in 8 pediatric medical centers from PEDSnet. We included 1139 children hospitalized with MIS-C and used their demographics, symptoms, conditions, laboratory values, and medications for analyses. We applied heterogeneity-adaptive latent class analyses and identified three latent classes. We further characterized the sociodemographic and clinical characteristics of the latent classes and evaluated their temporal patterns. Class 1 (47.9%) represented children with the most severe presentation, with more admission to the ICU, higher inflammatory markers, hypotension/shock/dehydration, cardiac involvement, acute kidney injury and respiratory involvement. Class 2 (23.3%) represented a moderate presentation, with 4–6 organ systems involved, and some overlapping features with acute COVID-19. Class 3 (28.8%) represented a mild presentation. Our results indicated that MIS-C has a spectrum of clinical severity ranging from mild to severe and the proportion of severe or critical MIS-C decreased over time.
dc.description.abstractStudy to characterize the illness spectrum of MIS-C for improved recognition and management.
dc.identifier.urihttps://pedsnet.org/metadata/handle/20.500.14642/897
dc.publisherPEDSnet
dc.relation.isreferencedbyRao, S., Jing, N., Liu, X. et al. 2023. "Spectrum of severity of multisystem inflammatory syndrome in children: an EHR-based cohort study from the RECOVER program." _Scientific Reports_. 13, 21005 (2023). <br>DOI:[10.1038/s41598-023-47655-y](doi.org/10.1038/s41598-023-47655-y)
dc.rightsa CC-BY 4.0 Attribution license.
dc.rights.urihttps://creativecommons.org/licenses/by-sa/4.0/
dc.subjectPEDSnet Study
dc.subjectRetrospective Study
dc.subject.meshCOVID-19
dc.subject.meshSARS-CoV-2
dc.subject.meshCoronavirus Infections
dc.subject.meshPneumonia, Viral
dc.titleSpectrum of Severity of Multisystem Inflammatory Syndrome in Children: An EHR-based Cohort Study from the RECOVER program
dc.title.alternativeA Y1 Q3 RECOVER program deliverable. Formerly Titled "Pediatric Nirmatrelvir/Ritonavir Prescribing Patterns During the COVID-19 Pandemic"
dspace.entity.typeStudy
local.admin.noteNational Institutes of Health (NIH) Agreement OT2HL161847-01 as part of the Researching COVID to Enhance Recovery (RECOVER) program of research.
local.subject.flatPEDSnet Data Source
local.subject.flatRetrospective Study
local.subject.flatCohort Study
local.subject.flatFederally Funded Research
project.startDate2023
relation.isStudyOfStudy4932bc8c-1f72-44ad-aeeb-b7922e38fad3
relation.isStudyOfStudy.latestForDiscovery4932bc8c-1f72-44ad-aeeb-b7922e38fad3

Files